Timil Patel, MD, discusses how to sequence therapies in a patient with rectal cancer with a single lung nodule.
Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses how to sequence therapies in a patient with rectal cancer with a single lung nodule.
Sequencing therapies in this patient population depends on how effective the first line of therapy is, says Patel. Generally, the first line of therapy will be a systemic therapy. Later on, Patel says patients will be restaged to make sure there is no further progression, and that the primary and metastatic sites have regressed in the patient.
The next steps for this patient include a discussion with a multidisciplinary board or tumor board. Most centers will agree that in rectal cancer with a single site that has a good response to chemotherapy, the next line of therapy would be to treat the primary cancer with chemoradiotherapy, says Patel. The goal of this treatment is to cure the patient, he adds.
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers
December 20th 2024During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.
Read More
AI-Driven Deep Learning Model Shows Promise in Standardizing MDS Diagnosis
December 10th 2024In an interview, Palak Dave discussed how artificial intelligence, using deep learning to analyze bone marrow aspirate smear images, could standardize and accelerate the diagnosis of MDS vs pre-MDS conditions.
Read More